News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
812,691 Results
Type
Article (78691)
Company Profile (514)
Press Release (733466)
Multimedia
Podcasts (189)
Webinars (27)
Section
Business (213416)
Career Advice (3715)
Deals (37779)
Drug Delivery (151)
Drug Development (88678)
Employer Resources (193)
FDA (18228)
Job Trends (16551)
News (370838)
Policy (37988)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3007)
Academic (1)
Accelerated approval (37)
Adcomms (36)
Allergies (154)
Alliances (54734)
ALS (184)
Alzheimer's disease (1812)
Antibody-drug conjugate (ADC) (360)
Approvals (18417)
Artificial intelligence (616)
Autoimmune disease (181)
Automation (43)
Bankruptcy (389)
Best Places to Work (12454)
BIOSECURE Act (23)
Biosimilars (208)
Biotechnology (347)
Bladder cancer (166)
Brain cancer (67)
Breast cancer (678)
Cancer (5156)
Cardiovascular disease (457)
Career advice (3180)
Career pathing (42)
CAR-T (315)
CDC (62)
Celiac Disease (2)
Cell therapy (857)
Cervical cancer (37)
Clinical research (74953)
Collaboration (1885)
Company closure (5)
Compensation (1205)
Complete response letters (78)
COVID-19 (2994)
CRISPR (105)
C-suite (924)
Cystic fibrosis (155)
Data (6452)
Decentralized trials (2)
Denatured (66)
Depression (158)
Diabetes (542)
Diagnostics (7171)
Digital health (53)
Diversity (13)
Diversity, equity & inclusion (47)
Drug discovery (300)
Drug pricing (226)
Drug shortages (36)
Duchenne muscular dystrophy (249)
Earnings (87278)
Editorial (67)
Employer branding (24)
Employer resources (165)
Events (128259)
Executive appointments (1051)
FDA (21499)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1592)
Gene editing (225)
Generative AI (60)
Gene therapy (692)
GLP-1 (1143)
Government (5367)
Grass and pollen (8)
Guidances (386)
Healthcare (20622)
HIV (66)
Huntington's disease (51)
IgA nephropathy (88)
Immunology and inflammation (306)
Immuno-oncology (65)
Indications (116)
Infectious disease (3301)
Inflammatory bowel disease (212)
Inflation Reduction Act (17)
Influenza (129)
Intellectual property (264)
Interviews (724)
IPO (17406)
IRA (61)
Job creations (4477)
Job search strategy (2567)
JPM (70)
Kidney cancer (17)
Labor market (92)
Layoffs (650)
Leadership (42)
Legal (9309)
Liver cancer (99)
Longevity (15)
Lung cancer (696)
Lymphoma (390)
Machine learning (45)
Management (63)
Manufacturing (881)
MASH (179)
Medical device (14774)
Medtech (14831)
Mergers & acquisitions (21476)
Metabolic disorders (1435)
Multiple sclerosis (173)
NASH (23)
Neurodegenerative disease (370)
Neuropsychiatric disorders (105)
Neuroscience (3183)
Neurotech (1)
NextGen: Class of 2026 (7436)
Non-profit (5100)
Now hiring (62)
Obesity (702)
Opinion (341)
Ovarian cancer (171)
Pain (219)
Pancreatic cancer (241)
Parkinson's disease (305)
Partnered (37)
Patents (531)
Patient recruitment (520)
Peanut (61)
People (63614)
Pharmaceutical (93)
Pharmacy benefit managers (33)
Phase 1 (23219)
Phase 2 (32628)
Phase 3 (24590)
Pipeline (5561)
Policy (346)
Postmarket research (3255)
Preclinical (10352)
Press Release (72)
Prostate cancer (254)
Psychedelics (60)
Radiopharmaceuticals (308)
Rare diseases (957)
Real estate (6826)
Recruiting (78)
Regulatory (28161)
Reports (56)
Research institute (2724)
Resumes & cover letters (589)
Rett syndrome (28)
RNA editing (21)
RSV (88)
Schizophrenia (162)
Series A (265)
Series B (204)
Service/supplier (18)
Sickle cell disease (106)
Special edition (28)
Spinal muscular atrophy (178)
Sponsored (49)
Startups (3982)
State (2)
Stomach cancer (20)
Supply chain (114)
Tariffs (101)
The Weekly (121)
Vaccines (1175)
Venture capital (101)
Weight loss (479)
Women's health (96)
Worklife (22)
Date
Today (173)
Last 7 days (632)
Last 30 days (2449)
Last 365 days (32347)
2026 (4067)
2025 (32590)
2024 (37535)
2023 (42316)
2022 (53640)
2021 (58382)
2020 (57175)
2019 (50553)
2018 (38489)
2017 (36231)
2016 (36689)
2015 (42520)
2014 (36467)
2013 (32468)
2012 (34183)
2011 (34352)
2010 (33552)
Location
Africa (1168)
Alabama (92)
Alaska (7)
Arizona (325)
Arkansas (14)
Asia (48397)
Australia (8448)
California (11758)
Canada (3377)
China (1202)
Colorado (494)
Connecticut (514)
Delaware (350)
Europe (111276)
Florida (1755)
Georgia (374)
Hawaii (4)
Idaho (67)
Illinois (965)
India (72)
Indiana (548)
Iowa (24)
Japan (449)
Kansas (134)
Kentucky (43)
Louisiana (29)
Maine (84)
Maryland (1468)
Massachusetts (8640)
Michigan (353)
Minnesota (668)
Mississippi (6)
Missouri (143)
Montana (36)
Nebraska (29)
Nevada (128)
New Hampshire (85)
New Jersey (3172)
New Mexico (33)
New York (3118)
North Carolina (1618)
North Dakota (10)
Northern California (5700)
Ohio (358)
Oklahoma (23)
Oregon (45)
Pennsylvania (2343)
Puerto Rico (25)
Rhode Island (47)
South America (1553)
South Carolina (68)
South Dakota (1)
Southern California (4563)
Tennessee (177)
Texas (1840)
United States (42299)
Utah (348)
Vermont (1)
Virginia (285)
Washington D.C. (88)
Washington State (978)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
812,691 Results for "the michael j fox foundation for parkinson s research".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease
January 29, 2026
·
7 min read
Press Releases
Bexorg Awarded Grant from The Michael J. Fox Foundation to Identify Translational Biomarkers for TRPML1-Targeted Parkinson’s Disease Therapies
January 29, 2026
·
4 min read
Press Releases
Booster Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to Advance New Class of Proteasome Activator Medicines Towards First-in-Human Phase 1 Study
November 14, 2025
·
3 min read
Press Releases
ABLi Therapeutics Completes Collaboration Agreement with The Michael J. Fox Foundation to include Risvodetinib in Path to Prevention Platform Trial
January 28, 2026
·
4 min read
Press Releases
Rhineland-Palatinate Biotech Company MODAG Receives Research Grant Funding from The Michael J. Fox Foundation
December 18, 2025
·
3 min read
Press Releases
Vincere Biosciences Awarded $5 Million from The Michael J. Fox Foundation to Advance Parkinson’s Therapeutic Toward Clinical Trials
November 19, 2025
·
4 min read
Business
MilliporeSigma and The Michael J. Fox Foundation Offer Service to Advance Parkinson’s Research
MilliporeSigma and The Michael J. Fox Foundation for Parkinson’s Research (MJFF), are advancing research aimed at slowing progression of Parkinson’s disease (PD).
June 18, 2024
·
4 min read
Press Releases
Lysoway Therapeutics Awarded Grant from The Michael J. Fox Foundation to Advance TRPML1 Agonist to Treat Parkinson’s Disease
August 6, 2025
·
1 min read
Press Releases
SciNeuro Pharmaceuticals to Accelerate Novel LRRK2 Therapeutic (SNP614) Development with an Award from The Michael J. Fox Foundation
November 21, 2025
·
4 min read
Pharm Country
Kannalife Secures Funding of $1.49 Million from The Michael J. Fox Foundation for Parkinson’s Research
Kannalife Sciences, Inc. is pleased to announce it has been awarded funding of $1,493,409 million from The Michael J. Fox Foundation for Parkinson’s Research.
June 25, 2024
·
4 min read
1 of 81,270
Next
